Fundraising FoxSpheryx
New York, US · Founded 2014 · New York corporation
Find your way into Spheryx
799 people in our graph share verified history with the Spheryx team — schools, employers, funds. One of them is your warm intro.
Gayathri (G) Radhakrishnanunlockedknows Laura Philips · together at Corning Incorporated (overlapped)
×5knows the team · via Corning Incorporated
×4knows the team · via U.S. Department of Commerce
×2knows the team · via White House Office of Science and Technology Policy
Spheryx develops Total Holographic Characterization technology for analyzing suspensions at the sub-visible particle level, including detecting protein aggregates and particles in biopharmaceuticals. Its analytical tools serve product development, manufacturing, and quality assurance across industries such as pharmaceuticals, cosmetics, chemicals, industrial fluids, and petroleum products.
Founders & leadership
Spheryx was founded in 2014 by Laura Philips.
LP
Laura PhilipsFounderLaura Philips holds a PhD in Chemistry from UC Berkeley and an MBA from Cornell. She previously served as COO/CFO at NexGenix Pharmaceuticals, held executive roles at Corning Incorporated focused on product development and strategic planning, and was CEO of WellGen Inc., a biotech company developing natural products, before founding Spheryx to develop holographic characterization technology for suspension analysis.
DG
David GrierNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.3M disclosed across 4 of 5 rounds · 2015–2026
▶$500.4KraisedJan 2026 · 1 investors · OtherRule 506(b)
▶$500.4KraisedJan 2026 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- David GrierDirector
- Laura PhilipsExecutive Officer, Director
- Offering amount
- $2.7M
- Amount sold
- $500.4K
- Minimum investment
- $36K
- First sale
- Jan 2026
- Incorporated
- Corporation, New York
- Federal exemptions
- 06b
▶$675KraisedApr 2023 · 4 investors · OtherRule 506(b)
▶$675KraisedApr 2023 · 4 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Laura PhilipsExecutive Officer, Director
- David GrierDirector
- Offering amount
- $2.8M
- Amount sold
- $675K
- Minimum investment
- $25K
- First sale
- Apr 2023
- Incorporated
- Corporation, New York
- Federal exemptions
- 06b
▶$525KraisedDec 2018 · 5 investors · OtherRule 506(b)
▶$525KraisedDec 2018 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- David GrierDirector
- Laura PhilipsExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $525K
- Minimum investment
- $50K
- Proceeds to insiders
- $1.3K
- First sale
- Dec 2018
- Incorporated
- Corporation, New York, 2014
- Federal exemptions
- 06b
▶$1MofferedOct 2017 · OtherRule 506(b)
▶$1MofferedOct 2017 · Other
Rule 506(b)Officers, directors & promoters on the filing
- David GrierDirector
- Laura PhilipsExecutive Officer, Director
- Offering amount
- $1M
- Minimum investment
- $50K
- Proceeds to insiders
- $1K
- Incorporated
- Corporation, New York, 2014
- Federal exemptions
- 06b
▶$575.8KraisedOct 2015 · 5 investors · OtherRule 506(b)
▶$575.8KraisedOct 2015 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Laura PhilipsExecutive Officer, Director
- David GrierDirector
- Offering amount
- $1.1M
- Amount sold
- $575.8K
- Minimum investment
- $50K
- Proceeds to insiders
- $1K
- First sale
- Jan 2015
- Incorporated
- Corporation, New York, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 5 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $1.6M |
| National Science Foundation | Phase II | 2016 | $748K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $318.3K |
| National Science Foundation | Phase I | 2015 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Spheryx do?
- Spheryx develops Total Holographic Characterization technology for analyzing suspensions at the sub-visible particle level, including detecting protein aggregates and particles in biopharmaceuticals. Its analytical tools serve product development, manufacturing, and quality assurance across industries such as pharmaceuticals, cosmetics, chemicals, industrial fluids, and petroleum products.
- Who founded Spheryx?
- Spheryx was founded by Laura Philips in 2014.
- How much funding has Spheryx raised?
- Spheryx has disclosed $2.3M raised across 4 of its 5 known rounds.
- Where is Spheryx headquartered?
- Spheryx is headquartered in New York, US.